Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000952477 | SCV001098983 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001091005 | SCV001818295 | likely benign | not provided | 2020-10-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002409269 | SCV002675444 | likely benign | Cardiovascular phenotype | 2022-03-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486951 | SCV004240686 | uncertain significance | Cardiomyopathy | 2023-06-07 | criteria provided, single submitter | clinical testing |